Oteseconazole for RVVC in diabetes: post-hoc analysis of safety and clinical response in phase 3 studies

被引：0
|
作者：
Nyirjesy, P. [1 ]
Sobel, J. D. [2 ]
Degenhardt, T. [3 ]
Weclaw, C. [3 ]
Person, K. [3 ]
Mcgaurn, S. [3 ]
Brand, S. [3 ]
机构：
[1] Thomas Jefferson Univ, Sidney Kimmel Coll, Sidney, BC, Canada
[2] Wayne State Univ, Sch Med, Wayne, NJ USA
[3] Mycovia Pharmaceut Inc, Durham, NC USA
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2023年 / 228卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
34
引用
收藏
页码：S784 / S784
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of galcanezumab in Taiwanese patients: a post-hoc analysis of phase 3 studies in episodic and chronic migraine
    Yang, Chun-Pai
    Lee, Chia-Fang
    Dell'Agnello, Grazia
    Hundemer, Hans-Peter
    Lipsius, Sarah
    Wang, Shuu-Jiun
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (10) : 1653 - 1666
  • [2] Combined Safety Data for Sutimlimab in Cold Agglutinin Disease: A Post-Hoc Analysis of the Phase 3 Cardinal and Cadenza Studies
    Broome, Catherine M.
    Barcellini, Wilma
    Ueda, Yasutaka
    Khan, Umer
    Patel, Reena
    Wardecki, Marek
    Kralova, Katarina
    Srivastava, Shruti
    Roeth, Alexander
    [J]. BLOOD, 2023, 142
  • [3] Magnitude and Duration of Early Response with Tofacitinib: Post-Hoc Analysis of Two Phase 3, Placebo-Controlled Studies
    Aletaha, Daniel
    Kivitz, Alan
    Valenzuela, Guillermo
    Tesser, John
    Hays, Steven
    Li, Huihua
    Connell, Carol A.
    Bananis, Eustratios
    Soonasra, Arif
    Smolen, Josef
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [4] MAGNITUDE AND DURATION OF EARLY RESPONSE WITH TOFACITINIB: POST-HOC ANALYSIS OF TWO PHASE 3, PLACEBO-CONTROLLED STUDIES
    Aletaha, D.
    Kivitz, A.
    Valenzuela, G.
    Tesser, J.
    Hays, S.
    Li, H.
    Connell, C. A.
    Bananis, E.
    Soonasra, A.
    Smolen, J. S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 272 - 273
  • [5] Predictors of Achievement of Response With Cenobamate: Post-hoc Subset Analysis From a Phase 3, Open-Label Safety Study
    Wechsler, Robert
    Vossler, David G.
    Kerr, Wesley T.
    Stern, Sean
    Wade, Clarence T.
    Rosenfeld, William E.
    [J]. NEUROLOGY, 2023, 100 (17)
  • [6] TOFACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS AND METABOLIC SYNDROME: A POST-HOC ANALYSIS OF PHASE 3 STUDIES
    Ritchlin, C.
    Giles, J.
    Ogdie, A.
    Gomez-Reino, J.
    Stockert, L.
    Young, P.
    Wang, C.
    Romero, A. B.
    Kudlacz, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1023 - 1023
  • [7] SAFETY PROFILE OF RISANKIZUMAB IN CROHN'S DISEASE PATIENTS BY AGE: POST-HOC ANALYSIS OF THE PHASE 3 ADVANCE, MOTIVATE, AND FORTIFY STUDIES
    Colombel, Jean Frederic
    Danese, Silvio
    Martin, Naomi
    Kligys, Kristina
    Zambrano, Javier A.
    Duan, W. Rachel
    Zhang, Yafei
    Koetse, Willem
    Panaccione, Remo
    D'Haens, Geert
    Ferrante, Marc
    Peyrin-Biroulet, Laurent
    [J]. GASTROENTEROLOGY, 2023, 164 (06) : S1091 - S1092
  • [8] Efficacy and Safety of Galcanezumab as a Preventive Treatment for Episodic Migraine in South Korean Patients: A Post-Hoc Analysis of a Phase 3 Clinical Trial
    Kim, Byung-Kun
    Cho, Soo-Jin
    Han, Jeong Hee
    Dell'Agnello, Grazia
    Panni, Tommaso
    Kim, Manho
    Oh, Kyungmi
    Moon, Heui-Soo
    Chu, Min Kyung
    [J]. JOURNAL OF CLINICAL NEUROLOGY, 2023, 19 (05): : 483 - 494
  • [9] Efficacy and safety of fremanezumab in patients with migraine and obesity: post-hoc analysis of the phase 3 HALO-LTS and FOCUS clinical trials
    Irimia Sieira, P.
    Torphy, B.
    Ortega, M.
    Barash, S.
    Krasenbaum, L. J.
    Akcicek, H.
    Smith, M.
    Ning, X.
    Campos, V. Ramirez
    [J]. JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [10] Safety of hepatitis E vaccination for pregnancy: a post-hoc analysis of a randomized, double-blind, controlled phase 3 clinical trial
    Zhong, Guohua
    Zhuang, Chunlan
    Hu, Xiaowen
    Chen, Qi
    Bi, Zhaofeng
    Jia, Xinhua
    Peng, Siying
    Li, Yufei
    Huang, Yue
    Zhang, Qiufen
    Hong, Ying
    Qiao, Youlin
    Su, Yingying
    Pan, Huirong
    Wu, Ting
    Wei, Lihui
    Huang, Shoujie
    Zhang, Jun
    Xia, Ningshao
    [J]. EMERGING MICROBES & INFECTIONS, 2023, 12 (01)
12345